RBC Capital analyst Deane Dray raised the firm’s price target on 3M (MMM) to $130 from $120 but keeps an Underperform rating on the shares. The company delivered a modest but broad-based Q3 operating beat and raise, with the positives that included stronger organic growth and progress on new product introductions, the analyst tells investors in a research note. RBC adds however that it continues to believe that the looming five categories of unaddressed and unreserved of multi-billion-dollar PFAS litigation is an underappreciated risk to the story.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MMM:
